Pharming Group NV (PHAR)
12.28
-0.31
(-2.46%)
USD |
NASDAQ |
Jun 10, 16:00
12.59
+0.31
(+2.52%)
After-Hours: 20:00
Pharming Group Max Drawdown (5Y) : 60.45% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 60.45% |
| April 30, 2026 | 60.45% |
| March 31, 2026 | 60.45% |
| February 28, 2026 | 60.45% |
| January 31, 2026 | 60.45% |
| December 31, 2025 | 60.45% |
| November 30, 2025 | 60.45% |
| October 31, 2025 | 60.45% |
| September 30, 2025 | 60.45% |
| August 31, 2025 | 60.45% |
| July 31, 2025 | 60.45% |
| June 30, 2025 | 60.45% |
| May 31, 2025 | 60.45% |
| April 30, 2025 | 60.45% |
| March 31, 2025 | 60.45% |
| February 28, 2025 | 60.45% |
| January 31, 2025 | 60.45% |
| December 31, 2024 | 60.45% |
| November 30, 2024 | 60.45% |
| October 31, 2024 | 60.45% |
| September 30, 2024 | 60.45% |
| August 31, 2024 | 60.45% |
| July 31, 2024 | 60.45% |
| June 30, 2024 | 60.45% |
| May 31, 2024 | 60.45% |
| Date | Value |
|---|---|
| April 30, 2024 | 60.45% |
| March 31, 2024 | 60.45% |
| February 29, 2024 | 60.45% |
| January 31, 2024 | 60.45% |
| December 31, 2023 | 60.45% |
| November 30, 2023 | 60.45% |
| October 31, 2023 | 60.45% |
| September 30, 2023 | 60.45% |
| August 31, 2023 | 60.45% |
| July 31, 2023 | 60.45% |
| June 30, 2023 | 60.45% |
| May 31, 2023 | 60.45% |
| April 30, 2023 | 60.45% |
| March 31, 2023 | 60.45% |
| February 28, 2023 | 60.45% |
| January 31, 2023 | 60.45% |
| December 31, 2022 | 60.45% |
| November 30, 2022 | 60.45% |
| October 31, 2022 | 60.45% |
| September 30, 2022 | 60.45% |
| August 31, 2022 | 60.45% |
| July 31, 2022 | 60.45% |
| June 30, 2022 | 60.45% |
| May 31, 2022 | 56.29% |
| April 30, 2022 | 54.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ProQR Therapeutics NV | 97.50% |
| NewAmsterdam Pharma Co. NV | 66.23% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alkermes Plc | 68.08% |
| Alnylam Pharmaceuticals, Inc. | 42.46% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -1.770 |
| Beta (5Y) | -0.0388 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 47.88% |
| Historical Sharpe Ratio (5Y) | -0.0456 |
| Historical Sortino (5Y) | -0.1057 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.76% |